Efficiency of a DNA vaccine on allergic asthma

A. Tissot, F. Beilvert, J. Chesné, M. Langelot, D. Lair, M.A. Muller, B. Pitard, A. Magnan (Nantes, France)

Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation
Session: Asthma: mechanisms of airway inflammation
Session type: Thematic Poster Session
Number: 2368
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Tissot, F. Beilvert, J. Chesné, M. Langelot, D. Lair, M.A. Muller, B. Pitard, A. Magnan (Nantes, France). Efficiency of a DNA vaccine on allergic asthma. Eur Respir J 2012; 40: Suppl. 56, 2368

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Specific allergen immunotherapy of asthma combined with allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 441s
Year: 2006

Evaluation of six-year allergen immunotherapy in allergic rhinitis and allergic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 439s
Year: 2006

The importance of pneumococcal and influenza vaccines in patients with allergic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 376s
Year: 2005

Specific immunotherapy in the management of allergic asthma
Source: Annual Congress 2008 - PG2 - Asthma: natural history, risk factors and overall management
Year: 2008



Immunotherapy prevents the development of asthma in subjects with allergic rhinitis
Source: Eur Respir J 2001; 18: Suppl. 33, 482s
Year: 2001

Translational strategy for allergic asthma
Source: International Congress 2014 – Sadoul Lecture “From molecules and cells to phenotypes: deciphering chronic airways disease” followed by related presentations
Year: 2014

Development of an integrated allergic rhinitis and asthma model with partial immunological tolerance
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009

Utility of Interleukin-5 in phenotyping allergic versus non allergic asthma
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021


Variants of allergic response in children with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 162s
Year: 2004

Intranasal and inhaled corticosteroids in allergic rhinitis and asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004

Impact of allergic rhinitis on asthma
Source: Annual Congress 2012 - PG6 Hot topics in paediatric allergy
Year: 2012



Does treatment of allergic rhinitis with intranasal steroids improve asthma control
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008


Comparison of late allergic inflammatory responses in asthma and rhinitis after nasal and bronchial allergen challenge
Source: Eur Respir J 2001; 18: Suppl. 33, 269s
Year: 2001

Treatment of co-morbid allergic asthma and perennial allergic rhinitis with the anti-IgE agent omalizumab
Source: Eur Respir J 2003; 22: Suppl. 45, 203s
Year: 2003

Evaluation and efficacy of allergen immunotherapy in asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 399s
Year: 2005

Allergic asthma: determinants of asthma control
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008

Therapeutic approach in allergic asthma: ASIT oposit to ICS
Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2010